News Focus
News Focus
icon url

KevGee59

04/24/25 10:53 AM

#763635 RE: FeMike #763634

20 mil at say .40 average = $8 million. What's their monthly burn rate. Does anyone have that handy?
icon url

Doc logic

04/24/25 11:07 AM

#763637 RE: FeMike #763634

FeMike,

Every day that passes without approval makes the decision look more and more like it is linked to manufacturing which is what you said you hoped it was not linked to over a year ago. When even the MP is upset that no approval has been given, a timing issue moves more and more into the forefront of the picture. Lots of money gets spent on resolving manufacturing and preparations for trials. Best wishes.
icon url

attilathehunt

04/24/25 11:12 AM

#763640 RE: FeMike #763634

What the hell are they spending this on?



EDEN units and MHRA fees!
icon url

learningcurve2020

04/24/25 11:16 AM

#763643 RE: FeMike #763634

Looks like Consultants and legal fees. 🤷‍♀️

>>What the hell are they spending this on? Crazy.
icon url

Investor082

04/24/25 11:54 AM

#763655 RE: FeMike #763634

This pump cycle is nothing but an effort to dump more shares by LP and Streeterville at higher price. We will be back in low 20 cents in May!

The minions are falsely building expectations around UK approval this month or next.

It ain’t coming in May either and unlikely in June either. It’s going to be Q3 at the earliest. And by then we will be trading in mid to low teens.

In addition to the UK approval timing (Q3), this dilution scheme also tells you they have nothing meaningful lined up post UK approval. She would have structured a cash loan rather than dilution of shares if significant upside was coming post UK approval.
icon url

RobotDroid

04/24/25 1:43 PM

#763702 RE: FeMike #763634

Spending on the GRIFT that never ends.
icon url

kabunushi

04/24/25 3:46 PM

#763757 RE: FeMike #763634

As of 1/1/2025 they had $31.4M in short term notes payable within this year. $3M that was due in Feb, the rest is listed in the 10k with 'various' for maturity dates. We don't know all the actual maturity dates, but that's a lot of shares that need to be issued either to pay in cash or tender as a conversion into shares for convertibles that are in the money at or before the time of maturity.

The maturities are set in the note contract - payment due dates are not at NW's discretion, i.e. they can't wait until the share price to go up before paying out. The 60M shares issued in Q1 must include 12M shares needed to pay off $3M notes that matured in Feb. Some of the convertibles convert as low as .26/shr. at the holder's option. Once the pps shot over that price it became advantageous for the holders to convert and receive now discounted shares rather than cash in payment. Once they get the shares, it's of course at their sole discretion as to when they liquidate them.
Under current conditions of volitility, the holder of the note that converts at .26 can make additional return above the interest rate if they convert now. But they expose themselves to market risk unless they turn around and sell the shares while it's profitable to do the conversion instead of getting paid off in cash. They get paid off with a hot potato.

Until we get details in a financial statement we can't know for sure what payments or debt conversion the shares we can see being issued for day to day. But investors should certainly be aware of how much those maturing debt obligations are. They account for some of the new shares being issued for sure, like the nearly $3M that came due in Feb. Again, if a note came due this month, NW probably wouldn't have a choice of when they have to issue the shares to cover the debt unless they negotiate a change in terms or in maturity, or conversion price for the convertible notes, etc.